Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$10.21 - $15.27 $11.1 Million - $16.6 Million
-1,084,229 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$14.07 - $17.3 $1.78 Million - $2.19 Million
126,353 Added 13.19%
1,084,229 $15.8 Million
Q2 2021

Aug 11, 2021

BUY
$16.62 - $18.94 $15.9 Million - $18.1 Million
957,876 New
957,876 $16.6 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.17B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Velanne Asset Management LTD Portfolio

Follow Velanne Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velanne Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Velanne Asset Management LTD with notifications on news.